Drug details

Zoryve (roflumilast cream)

type of Phosphodiesterase-4 Enzyme Inhibitors

Zoryve (roflumilast) Cream is a phosphodiesterase 4 inhibitor indicated for topical treatment of plaque psoriasis, including intertriginous areas, in patients 12 years of age and older.

This drug may have the following side effects:

• dizziness,
• depression,
• tremors
• hives, 
• difficulty breathing, 
• swelling of your face, lips, tongue, or throat, 
• anxiety,
• trouble sleeping,
• mood or behavior changes,
• thoughts of self-harm, 
• impulsive thoughts, 
• rapid and unintended weight loss, 
• pain or burning when you urinate, and 

The following drugs are related to Zoryve, either as a replacement or used together:

• Humira (adalimumab injection solution for subcutaneous administration)
• Avsola (infliximab-axxq for injection)
• Cosentyx (secukinumab injection)
• Daliresp (roflumilast)
• Duobrii (halobetasol propionate and tazarotene lotion)
• Enbrel (etanercept)
• Tremfya (guselkumab for injection)
• Inflectra (infliximab-dyyb intravenous injection)
• Remicade (infliximab)
• Taltz (ixekizumab injection, for subcutaneous use)
• Skyrizi (risankizumab-rzaa injection)
• Stelara Injection (ustekinumab)